NXP900 Phase 1b clinical program continues to enroll patients at select sites in the US NXP900 preclinical presentations at the 2026 American Association for Cancer Research (“AACR”) Annual Meeting” further support the clinical development strategyFORT LEE, N.J., May 05, 2026 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today reported its financial results for the first quarter of 2026 and provided an update on recent business progress. Ron Bentsur, Chairman and Chief Executive Officer of Nuvectis, commented, “2026 is off to a good start for Nuvectis as we advance the NXP900 Phase...

MALVERN, Pa., May 05, 2026 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced its financial and operating results for the first quarter of 2026. First Quarter 2026 HighlightsFirst quarter 2026 revenue of $34.5 million, up 8% compared to the first quarter 2025 U.S. clinic revenue of $21.5 million, up 15% compared to the first quarter 2025 Shipped 34 NeuroStar systems in the US; a 10% increase compared to the first quarter 2025 Net cash used in operations of $9.4 million, a reduction of $7.6 million compared to $17.0 million in the first quarter...

First quarter revenue of $194 million, a year-over-year increase of 15% as reported and 11% organic GAAP EPS increased 50% year-over-year and adjusted EPS increased 23% year-over-year Reiterating FY26 organic revenue growth guidance of 9%-13% and increasing adjusted EPS to $1.97-$2.05WALTHAM, Mass., May 05, 2026 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its first quarter of 2026, covering the three-month period ended March 31, 2026. The Company is also providing updated financial guidance for the full year 2026. Olivier Loeillot, President and Chief Executive Officer of Repligen said, “We delivered a very strong start to the year, achieving 11% organic revenue growth and 160 basis points of adjusted operating...

Development Timeline on Track at Barber Lake and Black Pearl Data Centers Signed Third AI Data Center Campus Lease with Investment-Grade Hyperscale Tenant Secured $200 Million Revolving Credit Facility Supported by a Syndicate of Leading Global Financial Institutions NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) — Cipher Digital Inc. (NASDAQ: CIFR) (“Cipher” or the “Company”), a leading developer, owner, and operator of industrial-scale data centers, today announced its first quarter 2026 financial results, with an update on its operations and business strategy. “2026 is the year of execution for Cipher,” said Tyler Page, Chief Executive Officer. “We are proud to announce massive development progress at both the Barber Lake and Black Pearl campuses. On the business development front, we built on the strong momentum from last year by signing...

NEWPORT NEWS, Va., May 05, 2026 (GLOBE NEWSWIRE) — HII (NYSE: HII) today reported results for the first quarter of fiscal 2026. HighlightsFirst quarter revenues were $3.1 billion First quarter net earnings were $149 million or $3.79 diluted earnings per share Completed builder’s sea trials for aircraft carrier John F. Kennedy (CVN 79) New collective bargaining agreements ratified at Ingalls Shipbuilding that extend through 2031 Company reaffirms previously issued FY26 financial guidance1First Quarter ResultsFirst quarter 2026 revenues of $3.1 billion were up 13.4% from the first quarter of 2025, driven by growth at Newport News Shipbuilding, Ingalls Shipbuilding and Mission Technologies. Operating income in the first quarter of 2026 was $155 million and operating margin was 5.0%, compared to $161 million and 5.9%, respectively,...

SPOKANE, Wash., May 05, 2026 (GLOBE NEWSWIRE) — Avista Corp. (NYSE: AVA) today reported net income based on GAAP of $92 million, or $1.11 per diluted share, for the first quarter of 2026, compared to $79 million, or $0.98 per diluted share, in 2025. Non-GAAP utility earnings1 were $91 million, or $1.10 per diluted share, compared to $82 million, or $1.01 per diluted share in 2025. Avista Corp. is confirming its 2026 non-GAAP utility earnings guidance2 with a range of $2.52 to $2.72 per diluted share. CEO Perspective “Strong performance in the first quarter demonstrates our focus on fundamentals: safety, reliability, and sound operational and financial execution. Our continued investments ensure we meet the needs of the communities we serve and also build long-term value for our customers, communities and shareholders. We are on...

~ Advancing FDA interactions on AMT-130 for Huntington’s disease; Type B meeting scheduled for the second quarter of 2026 ~ ~ Progressing AMT-130 toward expected UK regulatory submission; MAA on track for third quarter of 2026 following successful pre-submission meeting with UK MHRA ~ ~ Enrollment in AMT-260 temporal lobe epilepsy program on track; clinical update from first cohort in Phase I/IIa study to be presented at the Epilepsy Foundation Pipeline Conference ~ ~ Presented updated data from AMT-191 Phase I/IIa in Fabry disease study showed sustained increases in α-Gal A Enzyme Activity and stable Lyso-Gb3 levels; subsequently all 11 dosed patients have discontinued enzyme replacement therapy ~ ~ Strong balance sheet with $586.6 million in cash, cash equivalents and current investment securities as of March 31, 2026 and runway into...

Q1 2026 net revenues increased 10.0%, or 6.5% on a constant currency basis, compared to Q1 2025 Q1 2026 net income of $27 million or $0.09 per diluted share, compared to a net loss of $13 million or $0.05 per diluted share in Q1 2025 Q1 2026 Adjusted EBITDA(1) increased 10.5%, or 6.9% on a constant currency basis Q1 2026 Adjusted EPS(1) of $0.18, an increase of 29% per diluted share Company reaffirms full-year 2026 outlook of 5.0% – 6.5% net revenues growth and 5.5% – 7.0% Adjusted EBITDA growth, both on a constant currency basis Company announced planned CEO transition in a separate release todayCLEVELAND, May 05, 2026 (GLOBE NEWSWIRE) — Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory...

GAAP revenue decrease of 2% and organic revenue decrease of 4%;GAAP EPS decreased 29% and adjusted EPS decreased 16%;Company affirms 2026 organic revenue growth outlook of 1% to 3%and adjusted EPS outlook of $8.00 to $8.30 MILWAUKEE, May 05, 2026 (GLOBE NEWSWIRE) — Fiserv, Inc. (NASDAQ: FISV), a leading global provider of payments and financial services technology solutions, today reported financial results for the first quarter of 2026. First Quarter 2026 GAAP Results GAAP revenue for the company was $5.03 billion in the first quarter of 2026, a decrease of 2% compared to the first quarter of 2025. GAAP revenue was flat in the Merchant Solutions segment and decreased 5% in the Financial Solutions segment in the first quarter of 2026 compared to the prior year period. GAAP earnings per share was $1.07 in the first quarter of 2026,...

Double-digit year-over-year growth in revenue, origination volume, and total servicing UPB; Originations profitability partially offset higher MSR runoff WEST PALM BEACH, Fla., May 05, 2026 (GLOBE NEWSWIRE) — Onity Group Inc. (NYSE: ONIT) (“Onity” or the “Company”) today announced its first quarter 2026 results. First Quarter 2026:Net income attributable to common stockholders of $7 million; diluted EPS of $0.74; ROE of 4% Adjusted pre-tax loss* of $6 million, resulting in annualized adjusted ROE* of (4%), includes impact of mortgage interest rate volatility, higher than expected refinancing activity, and elevated FHA delinquencies $294 million in total revenue, up 18% vs Q1 2025; $278 million in adjusted revenue,* up 26% vs Q1 2025 $28 billion in total servicing additions, including $20 billion in MSR additions $338 billion in...